2.50
Hdl Handle:
http://hdl.handle.net/10755/154234
Type:
Presentation
Title:
Symptom Distress in Women with Breast Cancer
Abstract:
Symptom Distress in Women with Breast Cancer
Conference Sponsor:Sigma Theta Tau International
Conference Year:2007
Author:Lyon, Debra, RN, PhD
P.I. Institution Name:Virginia Commonwealth University
Title:Associate Professor
[Research Presentation] Purpose: Approximately 50% of cancer patients experience psychological distress; rates of fatigue and sleep disturbance range from 4 to 91%. Even though single symptoms have been well-described, there are few prospective studies of the co-occurrence of common symptoms including depression, fatigue and sleep disturbances, which may comprise a "cluster" in women with breast cancer. Therefore, further characterization and examination of this hypothesized symptom cluster in women with breast cancer is needed. Method: These data are reported as part (N=30) of a clinical trial (R21CA106149) to test the effects of cranial electric stimulation on psychological distress, symptoms and immune parameters in women with breast cancer. Women newly diagnosed with breast cancer were enrolled and measures were collected prior to their first chemotherapy and prior to receiving the study intervention. Women currently on antidepressant medication were excluded. In conjunction with collection of serum samples, participants completed the Hospital Anxiety and Depression Scale (HADS), the Brief Fatigue Inventory (BFI), the Brief Pain Inventory (BPI) and the General Sleep Disturbance Scale (GSDS). Findings: Scores on the HADS were elevated. 42% of participants scored > 8 on anxiety and 27% > 7 on depression. Similarly, scores on the BFI were elevated, but fewer met criteria for severe fatigue. Participants had moderate difficulty sleeping while pain was less severe than other symptoms. Discussion: Even though women receiving antidepressant therapy were excluded from this study, rates of anxiety and depressive symptoms were high. Both anxiety and depressive symptoms were correlated with fatigue and sleep disturbances, providing some evidence for a "cluster" of co-occurring symptoms
Repository Posting Date:
26-Oct-2011
Date of Publication:
17-Oct-2011
Sponsors:
Sigma Theta Tau International

Full metadata record

DC FieldValue Language
dc.typePresentationen_GB
dc.titleSymptom Distress in Women with Breast Canceren_GB
dc.identifier.urihttp://hdl.handle.net/10755/154234-
dc.description.abstract<table><tr><td colspan="2" class="item-title">Symptom Distress in Women with Breast Cancer</td></tr><tr class="item-sponsor"><td class="label">Conference Sponsor:</td><td class="value">Sigma Theta Tau International</td></tr><tr class="item-year"><td class="label">Conference Year:</td><td class="value">2007</td></tr><tr class="item-author"><td class="label">Author:</td><td class="value">Lyon, Debra, RN, PhD</td></tr><tr class="item-institute"><td class="label">P.I. Institution Name:</td><td class="value">Virginia Commonwealth University</td></tr><tr class="item-author-title"><td class="label">Title:</td><td class="value">Associate Professor</td></tr><tr class="item-email"><td class="label">Email:</td><td class="value">delyon@vcu.edu</td></tr><tr><td colspan="2" class="item-abstract">[Research Presentation] Purpose: Approximately 50% of cancer patients experience psychological distress; rates of fatigue and sleep disturbance range from 4 to 91%. Even though single symptoms have been well-described, there are few prospective studies of the co-occurrence of common symptoms including depression, fatigue and sleep disturbances, which may comprise a &quot;cluster&quot; in women with breast cancer. Therefore, further characterization and examination of this hypothesized symptom cluster in women with breast cancer is needed. Method: These data are reported as part (N=30) of a clinical trial (R21CA106149) to test the effects of cranial electric stimulation on psychological distress, symptoms and immune parameters in women with breast cancer. Women newly diagnosed with breast cancer were enrolled and measures were collected prior to their first chemotherapy and prior to receiving the study intervention. Women currently on antidepressant medication were excluded. In conjunction with collection of serum samples, participants completed the Hospital Anxiety and Depression Scale (HADS), the Brief Fatigue Inventory (BFI), the Brief Pain Inventory (BPI) and the General Sleep Disturbance Scale (GSDS). Findings: Scores on the HADS were elevated. 42% of participants scored &gt; 8 on anxiety and 27% &gt; 7 on depression. Similarly, scores on the BFI were elevated, but fewer met criteria for severe fatigue. Participants had moderate difficulty sleeping while pain was less severe than other symptoms. Discussion: Even though women receiving antidepressant therapy were excluded from this study, rates of anxiety and depressive symptoms were high. Both anxiety and depressive symptoms were correlated with fatigue and sleep disturbances, providing some evidence for a &quot;cluster&quot; of co-occurring symptoms</td></tr></table>en_GB
dc.date.available2011-10-26T12:50:37Z-
dc.date.issued2011-10-17en_GB
dc.date.accessioned2011-10-26T12:50:37Z-
dc.description.sponsorshipSigma Theta Tau Internationalen_GB
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.